What is the price target for CRIS stock?
10 analysts have analysed CRIS and the average price target is 14.28 USD. This implies a price increase of 2353.19% is expected in the next year compared to the current price of 0.5821.
NASDAQ:CRIS • US2312693094
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CURIS INC (CRIS).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-31 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-12-10 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-01 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-09-27 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-15 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-05-15 | Truist Securities | Maintains | Buy -> Buy |
| 2024-05-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-02-09 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-11-17 | Truist Securities | Initiate | Buy |
| 2023-09-29 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-09-25 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-09-07 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-08-04 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-07-11 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-07-07 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-05-05 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-11-10 | HC Wainwright & Co. | Maintains | Buy |
| 2021-10-13 | Raymond James | Initiate | Outperform |
| 2021-03-25 | B. Riley FBR | Initiate | Buy |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 10.023M -1.35% | 10.908M 8.83% | 9.443M -13.43% | 12.002M 27.10% | 20.132M 67.74% | 51.765M 157.13% | 121.38M 134.48% | 155.04M 27.73% | 160.14M 3.29% | 164.22M 2.55% | 169.32M 3.11% | |
| EBITDA YoY % growth | -48.077M 8.93% | -44.339M 7.78% | -32.733M 26.18% | -39.882M -21.84% | -13.158M 67.01% | -42.167M -220.47% | -44.115M -4.62% | -55.233M -25.20% | -53.101M 3.86% | -47.858M 9.87% | N/A | |
| EBIT YoY % growth | -48.332M 8.84% | -44.542M 7.84% | -32.902M 26.13% | -37.478M -13.91% | -37.594M -0.31% | -25.67M 31.72% | 42.84M 266.89% | 64.26M 50.00% | 61.2M -4.76% | 60.18M -1.67% | 59.16M -1.69% | |
| Operating Margin | -482.21% | -408.34% | -348.43% | -312.26% | -186.74% | -49.59% | 35.29% | 41.45% | 38.22% | 36.65% | 34.94% | |
| EPS YoY % growth | -8.96 26.56% | -7.03 21.54% | -2.92 58.46% | -2.12 27.46% | -0.72 65.81% | 0.05 106.34% | -0.40 -966.67% | -0.03 92.31% | 0.52 1,800.00% | 1.07 105.88% | 1.63 52.38% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.41 67.36% | -0.45 33.25% | -0.39 19.86% | 0.21 141.82% |
| Revenue Q2Q % growth | 1.516M -36.30% | 2.907M 5.75% | 3.162M -0.44% | 2.142M 88.22% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -8.178M 19.48% | -8.672M -5.11% | -8.77M -26.66% | -10.106M -33.50% |
All data in USD
10 analysts have analysed CRIS and the average price target is 14.28 USD. This implies a price increase of 2353.19% is expected in the next year compared to the current price of 0.5821.
CURIS INC (CRIS) will report earnings on 2026-05-04.
The consensus EPS estimate for the next earnings of CURIS INC (CRIS) is -0.41 USD and the consensus revenue estimate is 1.52M USD.
The consensus rating for CURIS INC (CRIS) is 82 / 100 . This indicates that analysts generally have a positive outlook on the stock.